SmartKem is expected to report a Q2 2026 loss of $0.30 per share on revenue of $0.03 million, with shares currently trading at $0.15 and no formal analyst price target available due to limited coverage. The primary focus for investors is the commercialization progress of the TRUFLEX® organic semiconductor platform, which is critical for the company’s expansion into the MicroLED and foldable display markets.
While the projected loss represents a narrowing from the -$0.98 reported in the prior year, revenue is anticipated to decline 20% year-over-year. With a market capitalization of only $4 million, the market will scrutinize updates on cash runway and potential strategic partnerships.